Diffusion-weighted MRI in renal cell carcinoma: A surrogate marker for predicting nuclear grade and histological subtype

Acta Radiologica

Volumn 53, Issue 3, 2012, Pages 349-358

  Goyal, Ankur ^a   Sharma, Raju ^a   Bhalla, Ashu S ^a   Gamanagatti, Shivanand ^a   Seth, Amlesh ^a   Iyer, Venkateswaran K ^a   Das, Prasenjit ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Adults; Kidney; MR diffusion perfusion; MR imaging; Neoplasms primary; Urinary

Indexed keywords

ADULTS; KIDNEY; MR IMAGING; MR-DIFFUSION/PERFUSION; NEOPLASMS - PRIMARY; URINARY;

CELLS; FORECASTING; MAGNETIC RESONANCE IMAGING; TUMORS;

CYTOLOGY;

BIOLOGICAL MARKER; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER STAGING; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ENHANCEMENT; KIDNEY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARCINOMA, RENAL CELL; COHORT STUDIES; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; KIDNEY; KIDNEY NEOPLASMS; MALE; MEGLUMINE; MIDDLE AGED; NEOPLASM STAGING; OBSERVER VARIATION; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84860205907     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2011.110415     Document Type: Article

References (36)

1. Jemal A Siegel R Ward E, et al. Cancer Statistics, 2009. CA Cancer J Clin 2009;59:225-49
2. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001;166:1611-23
3. Kutikov A, Kunkle DA, Uzzo RG. Focal therapy for kidney cancer: a systematic review. Curr Opin Urol 2009;19:148-53
4. Chen DY, Uzzo RG. Optimal management of localized renal cell carcinoma: surgery, ablation, or active surveillance. J Natl Compr Canc Netw 2009;7:635-42
5. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63 (Pubitemid 13234762)
6. Letourneux H, Lindner V, Lang H, et al. Reproducibility of Fuhrman nuclear grade: advantages of a two-grade system [in French]. Prog Urol 2006;16:281-5 (Pubitemid 44911967)
7. Bektas S, Bahadir B, Kandemir NO, et al. Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma. Kaohsiung J Med Sci 2009;25:596-600
8. Ficarra V, Martignoni G, Maffei N, et al. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 2005;103:68-75 (Pubitemid 39665458)
9. Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003;27:612-24 (Pubitemid 36514472)
10. Delahunt B, Bethwaite PB, Nacey JN. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 2007;39:459-65 (Pubitemid 47450591)
11. Gudbjartsson T, Hardarson S, Petursdottir V, et al. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Eur Urol 2005;48:593-600 (Pubitemid 41278584)
12. Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007;356:125-34 (Pubitemid 46089673)
13. [Published correction appears in N Engl J Med 2007;357:203]
14. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007;356:115-24 (Pubitemid 46089672)
15. Schrader AJ, Olbert PJ, Hegele A, et al. Metastatic non-clear cell renal cell carcinoma: current therapeutic options. BJU Int 2008;101:1343-5 (Pubitemid 351623979)
16. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11:102-25
17. Squillaci E, Manenti G, Di Stefano F, et al. Diffusion weighted MR imaging in the evaluation of renal tumours. J Exp Clin Cancer Res 2004;23:39-45 (Pubitemid 38552596)
18. Cova M, Squillaci E, Stacul F, et al. Diffusion weighted MRI in the evaluation of renal lesions: Preliminary results. Br J Radiol 2004;77:851-7 (Pubitemid 39504641)
19. Yoshikawa T, Kawamitsu H, Mitchell DG, et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. Am J Roentgenol 2006;187:1521-30 (Pubitemid 44788683)
20. Zhang J, Tehrani YM, Wang L, et al. Renal masses: characterization with diffusion-weighted MR imaging - A preliminary experience. Radiology 2008;247:458-64
21. Taouli B, Thakur R, Mannelli L, et al. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 2009;251:398-407
22. Kilickesmez O, Inci E, Atilla S, et al. Diffusion-weighted imaging of the renal and adrenal lesions. J Comput Assist Tomogr 2009;33:828-33
23. Sandrasegaran K, Sundaram CP, Ramaswamy R, et al. Usefulness of Diffusion-Weighted Imaging in the Evaluation of Renal Masses. Am J Roentgenol 2010;194:438-45
24. Thoeny HC, De Keyzer F, Oyen RH, et al. Diffusion- weighted MR imaging of kidneys in healthy volunteers and patients with parenchymal diseases- initial experience. Radiology 2005;235:911-7 (Pubitemid 40695889)
25. Chan JH Tsui EY, Luk SH, et al. MR diffusion-weighted imaging of kidney: differentiation between hydronephrosis and pyonephrosis. Clin Imaging 2001;25:110-3 (Pubitemid 32727702)
26. Verswijvel G, Vandecaveye V, Gelin G, et al. Diffusion-weighted MR imaging in the evaluation of renal infection: preliminary results. JBR-BTR 2002;85:100-3 (Pubitemid 34587151)
27. Goyal A, Gadodia A, Sharma R. Xanthogranulomatous pyelonephritis: an uncommon pediatric renal mass. Pediatr Radiol 2010;40:1962-3
28. Rosenkrantz AB, Niver BE, Fitzgerald EF, et al. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. Am J Roentgenol 2010;195: W344-51
29. Wang H, Cheng L, Zhang X, et al. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. Radiology 2010;257:135-43
30. Squillaci E, Manenti G, Cova M, et al. Correlation of diffusion-weighted MR imaging with cellularity of renal tumours. Anticancer Res 2004;24:4175-9 (Pubitemid 40468724)
31. Manenti G, Di Roma M, Mancino S, et al. Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3T. Radiol Med (Torino) 2008;113: 199-213 (Pubitemid 351666954)
32. Park SH, Moon WK, Cho N, et al. Diffusion-weighted MR Imaging: Pretreatment Prediction of Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer. Radiology 2010;257:56-63
33. McDonald K, Sebire NJ, Anderson J, et al. Patterns of shift in ADC distributions in abdominal tumours during chemotherapy-feasibility study. Pediatr Radiol 2011;41:99-106
34. Reuter VE. The pathology of renal epithelial neoplasms. Semin Oncol 2006;33:534-43 (Pubitemid 44511979)
35. Prasad SR, Humphrey PA, Catena JR, et al. Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics 2006;26:1795-806; discussion 1806-10
36. Grignon DJ, Eble JN Renal neoplasms. In: Jennette JC, Olson JL, Schwartz MM, et al., eds. Heptinstall's Pathology of the Kidney. 6th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2007:1492-531